Back to Search Start Over

Consensus on the management of patients with psoriatic arthritis in a dermatology setting.

Authors :
Gisondi P
Altomare G
Ayala F
Conti A
Dapavo P
De Simone C
Foti C
Idolazzi L
Lubrano E
Malara G
Marchesoni A
Olivieri I
Parodi A
Peris K
Piaserico S
Salvarani C
Scarpa R
Girolomoni G
Source :
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2018 Apr; Vol. 32 (4), pp. 515-528. Date of Electronic Publication: 2018 Jan 11.
Publication Year :
2018

Abstract

Background: Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis (PsO). Early diagnosis and prompt therapeutic intervention are crucial for limiting PsA progression and prevention of disability. Dermatologists are in a privileged position to detect early PsA. The management of patients with PsA in the dermatology setting is widely variable.<br />Objective: To provide practical recommendations for the management of patients with PsA in the dermatology setting including early diagnosis and treatment.<br />Methods: A consensus document was written by an expert panel composed by dermatologists (n = 12) and rheumatologists (n = 6). Eleven highly relevant questions were selected and elaborated with answers/statements based on a narrative literature review. The resulting document was discussed in a face-to-face meeting adopting a nominal group technique to reach consensus (i.e. 100% agreement) using the Delphi method.<br />Results: A consensus was achieved in defining the following: the clinical characteristics differentiating inflammatory and non-inflammatory signs and symptoms of joint disease; the most important differential diagnoses of PsA in clinical practice; the most useful screening questionnaires, serum laboratory tests and imaging techniques for the detection of early PsA; the criteria for dermatologist to refer patients with PsO to rheumatologist; the criteria for the diagnosis of PsA; the selection of the indices that the dermatologist could use for measuring the activity and severity of PsA in clinical practice; when systemic steroids and/or intra-articular steroid injections are indicated in the treatment of PsA. Finally, systemic treatments including synthetic and biologic disease-modifying antirheumatic drugs to be considered for the treatment of PsA have been reported.<br />Conclusions: The implementations of these practical recommendations could be very helpful for the management of patients with PsA in the dermatology setting including early diagnosis and treatment.<br /> (© 2017 European Academy of Dermatology and Venereology.)

Details

Language :
English
ISSN :
1468-3083
Volume :
32
Issue :
4
Database :
MEDLINE
Journal :
Journal of the European Academy of Dermatology and Venereology : JEADV
Publication Type :
Academic Journal
Accession number :
29220551
Full Text :
https://doi.org/10.1111/jdv.14741